Lataa...
New cast for a new era: preclinical cancer drug development revisited
Molecularly targeted agents promise to revolutionize therapeutics by reducing morbidity and mortality in patients with cancer. However, despite an urgent need for more effective anticancer compounds, current preclinical drug evaluations largely fail to satisfy the demand. New preclinical strategies,...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3754257/ https://ncbi.nlm.nih.gov/pubmed/23999436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI68340 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|